Given that APP/PS1 mice exhibit detectable Aβ plaques at the age of 6 months (Liu et al., 2020), 10-month-old AD and KOAD mice were examined to determine whether NP65 deficiency would affect Aβ levels and Aβ plaques in AD mice. This evidence concerns the gene NPTN and Alzheimer disease.